72 related articles for article (PubMed ID: 18275835)
1. Quantitative measurement of epidermal growth factor receptor-mitogen-activated protein kinase signal transduction using a nine-plex, peptide-based immunoassay.
Rauh-Adelmann C; Moskow JM; Graham JR; Yen LG; Boucher JI; Murphy CE; Nadler TK; Gordon NF; Radding JA
Anal Biochem; 2008 Apr; 375(2):255-64. PubMed ID: 18275835
[TBL] [Abstract][Full Text] [Related]
2. Profiling protein tyrosine phosphorylation: a quantitative 45-plex peptide-based immunoassay.
Nadler TK; Rauh-Adelmann C; Murphy C; Hall AB; Graham JR; Yen L; Gordon NF; Radding JA
J Biomol Screen; 2008 Aug; 13(7):626-37. PubMed ID: 18626117
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
Takeuchi K; Shin-ya T; Nishio K; Ito F
FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
[TBL] [Abstract][Full Text] [Related]
4. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
McDaneld TG; Spurlock DM
J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
[TBL] [Abstract][Full Text] [Related]
5. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
Kim SH; Song YC; Kim SH; Jo H; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
[TBL] [Abstract][Full Text] [Related]
7. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.
Perez-Torres M; Valle BL; Maihle NJ; Negron-Vega L; Nieves-Alicea R; Cora EM
Exp Cell Res; 2008 Oct; 314(16):2907-18. PubMed ID: 18687326
[TBL] [Abstract][Full Text] [Related]
8. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor promotes epidermal growth factor receptor nuclear accumulation by a pathway dependent on cytoskeleton integrity in human breast cancer cells.
Cortes-Reynosa P; Robledo T; Salazar EP
Arch Med Res; 2009 Jul; 40(5):331-8. PubMed ID: 19766894
[TBL] [Abstract][Full Text] [Related]
10. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
Mukherjee B; Mayer D
Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor is involved in clusterin-induced astrocyte proliferation.
Shim YJ; Shin YJ; Jeong SY; Kang SW; Kim BM; Park IS; Min BH
Neuroreport; 2009 Mar; 20(4):435-9. PubMed ID: 19218870
[TBL] [Abstract][Full Text] [Related]
12. Mevastatin-induced neurite outgrowth of neuroblastoma cells via activation of EGFR.
Evangelopoulos ME; Weis J; Krüttgen A
J Neurosci Res; 2009 Jul; 87(9):2138-44. PubMed ID: 19224573
[TBL] [Abstract][Full Text] [Related]
13. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
14. Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
Wang CY; Wang YT; Tzeng DW; Yang JL
Toxicol Appl Pharmacol; 2009 Mar; 235(2):244-52. PubMed ID: 19133285
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor.
Maegawa M; Arao T; Yokote H; Matsumoto K; Kudo K; Tanaka K; Kaneda H; Fujita Y; Ito F; Nishio K
Cancer Sci; 2009 Mar; 100(3):552-7. PubMed ID: 19154417
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
17. Peptide mimics of epidermal growth factor (EGF) with antagonistic activity.
Nakamura T; Takasugi H; Aizawa T; Yoshida M; Mizuguchi M; Mori Y; Shinoda H; Hayakawa Y; Kawano K
J Biotechnol; 2005 Mar; 116(3):211-9. PubMed ID: 15707681
[TBL] [Abstract][Full Text] [Related]
18. [The effects of genistein on tyrosine protein kinase-mitogen activated protein kinase signal transduction pathway in hypertrophic scar fibroblasts].
Cao C; Li SR; Dai X; Chen YQ; Feng Z; Qin X; Zhao Y; Wu J
Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):118-21. PubMed ID: 18785412
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
[TBL] [Abstract][Full Text] [Related]
20. S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.
Murillo-Carretero M; Torroglosa A; Castro C; Villalobo A; Estrada C
Free Radic Biol Med; 2009 Feb; 46(4):471-9. PubMed ID: 19056486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
